Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
SEND Format Conversion

SEND Format Conversion

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

SEND Format Conversion

Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission. In 2020, it helped customers complete 14 send data conversion projects, of which 3 new drug projects have obtained clinical licenses from FDA.
Medicilon diamond icon.pngSEND Format and FDA Declaration
What does the SEND format look like?
Medicilon diamond icon.pngStandard SEND Conversion Process
Medicilon diamond icon.pngThe Medicilon SEND Team Helps You Successfully Implement Data Conversion
Service Cases

Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use.webp

Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use

Learn More

three Bispecific Antibody Drugs Assisted by Medicilon were Approved.webp

Within 10 days, three Bispecific Antibody Drugs Assisted by Medicilon were Approved!

Learn More

 Medicilon assists Chipscreen Biosciences' CS12192 to be approved by the FDA
.webp

Medicilon assists Chipscreen Biosciences' CS12192 to be approved by the FDA

Learn More

Please Contact Us for More Cases:

Inquire

Relevant laboratories
prev page next page
  • frozen section
  • Pathological observation
  • pathological section
  • electrophysiology
  • electrophysiology 7
  • electrophysiology 5
Return